Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jul 21, 2011

Premium

Marina Biotech has appointed John Fletcher to its board of directors.

Fletcher replaces Chiang Li, who co-founded Marina acquisition Cequent Pharmaceuticals. He is an independent director and founding partner of venture capital firm Fletcher Spaght Ventures.

Marina also said that board member James Karis has been appointed as chairman, replacing co-chairmen Gregory Sessler and Peter Parker, both of whom will continue as board members.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.